Usefulness of B‐Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction

Author:

Liu Xiao123,Abudukeremu Ayiguli12,Yu Peng4,Cao Zhengyu12,Sun Runlu12,Wu Maoxiong12,Chen Zhiteng12,Ma Jianyong5,Zhu Wengen6ORCID,Chen Yangxin123,Zhang Yuling123ORCID,Wang Jingfeng123

Affiliation:

1. Department of Cardiology Sun Yat‐Sen Memorial Hospital, Sun Yat‐Sen University Guangzhou China

2. Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology Guangzhou China

3. Guangzhou Key Laboratory of Molecular Mechanism and Translation in Major Cardiovascular Disease, Sun Yat‐Sen Memorial Hospital Sun Yat‐Sen University Guangzhou China

4. Department of Endocrine The Second Affiliated Hospital of Nanchang University Jiangxi

5. Department of Pharmacology and Systems Physiology University of Cincinnati College of Medicine Cincinnati OH

6. Department of Cardiology The First Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

Abstract

Background B‐type natriuretic peptide (BNP) is a well‐known biomarker for prognosis in heart failure with patients with preserved ejection fraction. However, the clinical predictive ability of BNP for the risk of stroke in HFpEF is not clear. Methods and Results A total of 799 patients with HFpEF from the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) trial were included. Association of baseline BNP with risk of stroke was assessed using the Cox proportional hazard model. The discriminatory ability of BNP was expressed using the C index. The improvement in 5‐year stroke prediction was assessed by C statistic, categorical net reclassification improvement index, and relative integrated discrimination improvement. A total of 34 (4.3%) patients among the 799 patients with HFpEF experienced stroke events over a median of 2.85 years of follow‐up. The stroke group showed a higher BNP level than the nonstroke group (375 pg/mL versus 241 pg/mL, respectively; P =0.006). Higher BNP levels were associated with increased risk of stroke after multivariable adjustment (hazard ratio, 3.29 [95% CI, 1.51–7.16]) and had a moderate performance for stroke prediction (C index, 0.67). Adding BNP to CHADS 2 /CHA 2 DS 2 ‐VASc/R 2 CHADS 2 scores improved their predictive value for stroke (CHADS 2 : C index, 0.67; BNP+CHADS 2 : C index, 0.77; net reclassification improvement, 40.9%; integrated discrimination improvement, 3.0%; CHA 2 DS 2 ‐VASc: C index, 0.64; BNP+CHA 2 DS 2 ‐VASc: C index, 0.74; net reclassification improvement, 41.4%; integrated discrimination improvement, 2.2%; R 2 CHADS 2 : C index, 0.70; BNP+R 2 CHADS 2 : C index, 0.78; net reclassification improvement, 40.9%; integrated discrimination improvement, 3.2%). Conclusions BNP is associated with an increased risk of stroke in patients with HFpEF and may be a valuable biomarker for stroke prediction in HFpEF.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3